Physicians’ attitude towards selection of second line therapy with nilotinib and dasatinib in chronic myeloid leukemia patients

Overview of attention for article published in Health and Quality of Life Outcomes, October 2017

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 721 followers.

#HealthEconJA Physicians’ attitude towards selection of second line therapy with nilotinib and dasatinib in chroni… https://t.co/Xi19xCv5wJ

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.